Current Trials and Studies
Experimental stem cell therapy for swallowing disorders resulting from treatment for head and neck cancer.
ClinicalTrials.Gov Identifier: NCT05421689, UC Davis IRB#1851097
Description of the Clinical Trial: To compare the potential benefits of muscle stem cells injected into the tongue in subjects with moderate swallowing difficulty from head and neck cancer treatment to placebo. This is a double-blind, randomized, placebo-controlled Phase II clinical trial.
Principal Investigator: Peter Belafsky, M.D., M.P.H., Ph.D., Department of Otolaryngology
Study In-Take Questionnaire: https://ucdavis.co1.qualtrics.com/jfe/form/SV_4O9WMsjw9EKto6q
For questions about this clinical trial, please email: HS-ENTStemCell@ucdavis.edu.
Research Coordinator: Angela Beliveau, UC Davis Department of Otolaryngology.
ClinicalTrials.gov Identifier: NCT03739216 / UC Davis IRB# 1317894
Description of Research Study: A multi-center, prospective, non-randomized, observational registry to assess the results of the ClariFix(TM) device when used to ablate unwanted tissue in the nose of subjects with chronic rhinitis
Principal Investigator: Toby O. Steele, M.D., Department of Otolaryngology
Co-Investigators: Brad Strong, M.D., Lane Squires, M.D., Department of Otolaryngology
Research Coordinator: Randev Sandhu, UC Davis Department of Otolaryngology, 916-734-2863, email@example.com
Research joint email address: HS-OTO Study firstname.lastname@example.org